Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis.
|
Proc Natl Acad Sci U S A
|
2004
|
1.72
|
2
|
Images in clinical medicine. Pemberton's sign.
|
N Engl J Med
|
2004
|
1.47
|
3
|
Growth Hormone Therapy Accelerates Axonal Regeneration, Promotes Motor Reinnervation, and Reduces Muscle Atrophy following Peripheral Nerve Injury.
|
Plast Reconstr Surg
|
2016
|
1.43
|
4
|
Endocrine side effects induced by immune checkpoint inhibitors.
|
J Clin Endocrinol Metab
|
2013
|
1.42
|
5
|
Perioperative glucocorticoid prescribing habits in patients with inflammatory bowel disease: a call for standardization.
|
JAMA Surg
|
2014
|
1.37
|
6
|
Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study.
|
J Clin Endocrinol Metab
|
2010
|
1.24
|
7
|
Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia.
|
J Clin Endocrinol Metab
|
2002
|
1.18
|
8
|
Lack of evidence of premature atherosclerosis in untreated severe isolated growth hormone (GH) deficiency due to a GH-releasing hormone receptor mutation.
|
J Clin Endocrinol Metab
|
2006
|
1.15
|
9
|
Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults.
|
J Clin Endocrinol Metab
|
2007
|
1.14
|
10
|
Metabolic regulation of ghrelin O-acyl transferase (GOAT) expression in the mouse hypothalamus, pituitary, and stomach.
|
Mol Cell Endocrinol
|
2009
|
1.14
|
11
|
A mouse with targeted ablation of the growth hormone-releasing hormone gene: a new model of isolated growth hormone deficiency.
|
Endocrinology
|
2004
|
1.13
|
12
|
Effects of an oral growth hormone secretagogue in older adults.
|
J Clin Endocrinol Metab
|
2009
|
1.13
|
13
|
Glucocorticoid-induced loss of DNA methylation in non-neuronal cells and potential involvement of DNMT1 in epigenetic regulation of Fkbp5.
|
Biochem Biophys Res Commun
|
2012
|
1.12
|
14
|
Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene.
|
J Clin Endocrinol Metab
|
2009
|
1.09
|
15
|
On the shoulders of giants: Harvey Cushing's experience with acromegaly and gigantism at the Johns Hopkins Hospital, 1896-1912.
|
Pituitary
|
2011
|
1.09
|
16
|
Cushing syndrome: maybe not so uncommon of an endocrine disease.
|
J Am Board Fam Med
|
2012
|
1.04
|
17
|
Hypophysitis induced by monoclonal antibodies to cytotoxic T lymphocyte antigen 4: challenges from a new cause of a rare disease.
|
Oncologist
|
2012
|
0.99
|
18
|
Growth hormone-releasing hormone disruption extends lifespan and regulates response to caloric restriction in mice.
|
Elife
|
2013
|
0.97
|
19
|
Magnetic resonance imaging study of pituitary morphology in subjects homozygous and heterozygous for a null mutation of the GHRH receptor gene.
|
Eur J Endocrinol
|
2003
|
0.96
|
20
|
Insulin sensitivity and β-cell function in adults with lifetime, untreated isolated growth hormone deficiency.
|
J Clin Endocrinol Metab
|
2011
|
0.96
|
21
|
Endocrinological side-effects of immune checkpoint inhibitors.
|
Curr Opin Oncol
|
2016
|
0.96
|
22
|
Invasive adenoma and pituitary carcinoma: a SEER database analysis.
|
Neurosurg Rev
|
2014
|
0.94
|
23
|
Heterozygosity for a mutation in the growth hormone-releasing hormone receptor gene does not influence adult stature, but affects body composition.
|
J Clin Endocrinol Metab
|
2007
|
0.92
|
24
|
Impact of fluconazole prophylaxis on cortisol levels in critically ill surgical patients.
|
Antimicrob Agents Chemother
|
2004
|
0.92
|
25
|
Expanded endonasal endoscopic approach for resection of a growth hormone-secreting pituitary macroadenoma coexistent with a cavernous carotid artery aneurysm.
|
J Clin Neurosci
|
2012
|
0.91
|
26
|
Detection of pituitary antibodies by immunofluorescence: approach and results in patients with pituitary diseases.
|
J Clin Endocrinol Metab
|
2014
|
0.91
|
27
|
Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses.
|
Eur J Endocrinol
|
2013
|
0.90
|
28
|
Adipokine profile and urinary albumin excretion in isolated growth hormone deficiency.
|
J Clin Endocrinol Metab
|
2009
|
0.89
|
29
|
Complications and death among elderly patients undergoing pituitary tumour surgery.
|
Clin Endocrinol (Oxf)
|
2010
|
0.88
|
30
|
Isolated GH deficiency due to a GHRH receptor mutation causes hip joint problems and genu valgum, and reduces size but not density of trabecular and mixed bone.
|
J Clin Endocrinol Metab
|
2013
|
0.87
|
31
|
Pituitary antibodies in women with Hashimoto's thyroiditis: prevalence in diagnostic and prediagnostic sera.
|
Thyroid
|
2012
|
0.87
|
32
|
Pituitary and systemic autoimmunity in a case of intrasellar germinoma.
|
Pituitary
|
2009
|
0.86
|
33
|
Predictors of access to pituitary tumor resection in the United States, 1988-2005.
|
Eur J Endocrinol
|
2009
|
0.84
|
34
|
Diseases associated with growth hormone-releasing hormone receptor (GHRHR) mutations.
|
Prog Mol Biol Transl Sci
|
2009
|
0.84
|
35
|
Effects of recombinant mouse growth hormone treatment on growth and body composition in GHRH knock out mice.
|
Growth Horm IGF Res
|
2005
|
0.83
|
36
|
Clinical features of sellar and suprasellar meningiomas.
|
Pituitary
|
2014
|
0.83
|
37
|
Periodontal disease in adults with untreated congenital growth hormone deficiency: a case-control study.
|
J Clin Periodontol
|
2011
|
0.82
|
38
|
Treatment of pituitary adenomas using radiosurgery and radiotherapy: a single center experience and review of literature.
|
Neurosurg Rev
|
2010
|
0.82
|
39
|
ACTH-secreting pituitary microadenomas are associated with a higher prevalence of central hypothyroidism compared to other microadenoma types.
|
Clin Endocrinol (Oxf)
|
2012
|
0.82
|
40
|
Partial reversibility of growth hormone (GH) deficiency in the GH-releasing hormone (GHRH) knockout mouse by postnatal treatment with a GHRH analog.
|
Endocrinology
|
2004
|
0.82
|
41
|
Consequences of lifetime isolated growth hormone (GH) deficiency and effects of short-term GH treatment on bone in adults with a mutation in the GHRH-receptor gene.
|
Clin Endocrinol (Oxf)
|
2008
|
0.82
|
42
|
Lifetime congenital isolated GH deficiency does not protect from the development of diabetes.
|
Endocr Connect
|
2013
|
0.82
|
43
|
Prognostic value of exercise echocardiography in diabetic patients.
|
Cardiovasc Ultrasound
|
2009
|
0.82
|
44
|
Prevalence of antipituitary antibodies in acromegaly.
|
Pituitary
|
2012
|
0.81
|
45
|
Increased visceral adiposity and cortisol to cortisone ratio in adults with congenital lifetime isolated GH deficiency.
|
J Clin Endocrinol Metab
|
2014
|
0.81
|
46
|
Metabolic effects of growth hormone (GH) replacement in children and adolescents with severe isolated GH deficiency due to a GHRH receptor mutation.
|
Clin Endocrinol (Oxf)
|
2007
|
0.81
|
47
|
Effect of dopaminergic drug treatment on surgical findings in prolactinomas.
|
Pituitary
|
2011
|
0.81
|
48
|
Nelfinavir induces radiation sensitization in pituitary adenoma cells.
|
Cancer Biol Ther
|
2011
|
0.81
|
49
|
Expression of the pituitary stem/progenitor marker GFRα2 in human pituitary adenomas and normal pituitary.
|
Pituitary
|
2015
|
0.80
|
50
|
Thyroid morphology and function in adults with untreated isolated growth hormone deficiency.
|
J Clin Endocrinol Metab
|
2006
|
0.80
|
51
|
Variability in anterior pituitary size within members of a family with GH deficiency due to a new splice mutation in the GHRH receptor gene.
|
Clin Endocrinol (Oxf)
|
2004
|
0.80
|
52
|
Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not).
|
Cancer Chemother Pharmacol
|
2013
|
0.80
|
53
|
Familial Growth Hormone Deficiency and Mutations in the GHRH Receptor Gene.
|
Vitam Horm
|
2004
|
0.80
|
54
|
Visual vignette. Thyrotroph cell hyperplasia.
|
Endocr Pract
|
2012
|
0.80
|
55
|
Lifetime, untreated isolated GH deficiency due to a GH-releasing hormone receptor mutation has beneficial consequences on bone status in older individuals, and does not influence their abdominal aorta calcification.
|
Endocrine
|
2013
|
0.79
|
56
|
Lingual thyroid.
|
Endocrine
|
2013
|
0.79
|
57
|
Pituitary tumors.
|
Curr Treat Options Neurol
|
2009
|
0.79
|
58
|
Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults.
|
Pituitary
|
2013
|
0.79
|
59
|
Effects of long-term treatment with growth hormone-releasing peptide-2 in the GHRH knockout mouse.
|
Am J Physiol Endocrinol Metab
|
2005
|
0.79
|
60
|
Climacteric in untreated isolated growth hormone deficiency.
|
Menopause
|
2008
|
0.79
|
61
|
Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.
|
Am J Physiol Endocrinol Metab
|
2006
|
0.79
|
62
|
Vitamin A deficiency does not influence longitudinal growth in mice.
|
Nutrition
|
2007
|
0.79
|
63
|
A new missense mutation in the growth hormone-releasing hormone receptor gene in familial isolated GH deficiency.
|
Eur J Endocrinol
|
2003
|
0.79
|
64
|
A single injection of double-stranded adeno-associated viral vector expressing GH normalizes growth in GH-deficient mice.
|
J Endocrinol
|
2008
|
0.79
|
65
|
Long- but not short-term adult-onset, isolated GH deficiency in male mice leads to deterioration of β-cell function, which cannot be accounted for by changes in β-cell mass.
|
Endocrinology
|
2013
|
0.79
|
66
|
Molecular and clinical aspects of GHRH receptor mutations.
|
Endocr Dev
|
2013
|
0.79
|
67
|
[Growth or somatotrophic hormone: new perspectives in isolated GH deficiency after description of the mutation in the GHRH receptor gene in individuals of Itabaianinha County, Brazil].
|
Arq Bras Endocrinol Metabol
|
2004
|
0.78
|
68
|
Giant somatotrophinoma without acromegalic features: more "quiet" than "silent": case report.
|
Neurosurgery
|
2005
|
0.78
|
69
|
Influence of estrogen administration on the growth response to growth hormone (GH) in GH-deficient mice.
|
Exp Biol Med (Maywood)
|
2005
|
0.78
|
70
|
Laryngeal and vocal evaluation in untreated growth hormone deficient adults.
|
Otolaryngol Head Neck Surg
|
2009
|
0.78
|
71
|
Effects of combined long-term treatment with a growth hormone-releasing hormone analogue and a growth hormone secretagogue in the growth hormone-releasing hormone knock out mouse.
|
Neuroendocrinology
|
2006
|
0.78
|
72
|
Sizes of abdominal organs in adults with severe short stature due to severe, untreated, congenital GH deficiency caused by a homozygous mutation in the GHRH receptor gene.
|
Clin Endocrinol (Oxf)
|
2008
|
0.78
|
73
|
Diagnostic performance of multidetector computed tomography in distinguishing unilateral from bilateral abnormalities in primary hyperaldosteronism: comparison of multidetector computed tomography with adrenal vein sampling.
|
J Comput Assist Tomogr
|
2015
|
0.77
|
74
|
Naturally-occurring missense mutations in the human growth hormone-releasing hormone receptor alter ligand binding.
|
J Endocrinol
|
2005
|
0.77
|
75
|
Voice quality in short stature with and without GH deficiency.
|
J Voice
|
2012
|
0.77
|
76
|
Adult-onset growth hormone deficiency: causes, complications and treatment options.
|
Curr Opin Endocrinol Diabetes Obes
|
2008
|
0.77
|
77
|
Mutation analysis of the muscarinic cholinergic receptor genes in isolated growth hormone deficiency type IB.
|
J Clin Endocrinol Metab
|
2009
|
0.77
|
78
|
Second attempt to withdraw cabergoline in prolactinomas: a pilot study.
|
Pituitary
|
2014
|
0.77
|
79
|
Cephalometric features in isolated growth hormone deficiency.
|
Angle Orthod
|
2011
|
0.77
|
80
|
Growth and development: Growth hormone therapy--is it worth the risk?
|
Nat Rev Endocrinol
|
2012
|
0.77
|
81
|
Hearing status in adult individuals with lifetime, untreated isolated growth hormone deficiency.
|
Otolaryngol Head Neck Surg
|
2014
|
0.76
|
82
|
Effects of isolated GH deficiency on adipose tissue, feeding and adipokines in mice.
|
Growth Horm IGF Res
|
2013
|
0.76
|
83
|
Management options for persistent postoperative acromegaly.
|
Neurosurg Clin N Am
|
2012
|
0.76
|
84
|
Effects of GH deficiency and GH replacement on inter-male aggressiveness in mice.
|
Growth Horm IGF Res
|
2011
|
0.76
|
85
|
Perioperative corticosteroid management for patients with inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2015
|
0.76
|
86
|
Prolactin and sex steroids levels in congenital lifetime isolated GH deficiency.
|
Endocrine
|
2013
|
0.76
|
87
|
Partial rescue of growth failure in growth hormone (GH)-deficient mice by a single injection of a double-stranded adeno-associated viral vector expressing the GH gene driven by a muscle-specific regulatory cassette.
|
Hum Gene Ther
|
2009
|
0.76
|
88
|
Growth hormone should be used only for approved indications.
|
J Clin Endocrinol Metab
|
2013
|
0.76
|
89
|
A novel frame shift mutation in the GHRH receptor gene in familial isolated GH deficiency: early occurrence of anterior pituitary hypoplasia.
|
J Clin Endocrinol Metab
|
2011
|
0.76
|
90
|
ACTH-secreting pituitary adenomas: size does not correlate with hormonal activity.
|
Pituitary
|
2012
|
0.75
|
91
|
Genetic analysis in a patient presenting with meningioma and familial isolated pituitary adenoma (FIPA) reveals selective involvement of the R81X mutation of the AIP gene in the pathogenesis of the pituitary tumor.
|
Pituitary
|
2012
|
0.75
|
92
|
The consequences of growth hormone-releasing hormone receptor haploinsufficiency for bone quality and insulin resistance.
|
Clin Endocrinol (Oxf)
|
2012
|
0.75
|
93
|
Familial isolated pituitary adenomas: from genetics to therapy.
|
Clin Transl Sci
|
2011
|
0.75
|
94
|
A lifelong smoker with hypopituitarism: rethinking the hypothesis of a tumor in the hypophysis.
|
Case Rep Med
|
2012
|
0.75
|
95
|
MANAGEMENT OF CATECHOLAMINE-SECRETING TUMORS IN PREGNANCY: A REVIEW.
|
Endocr Pract
|
2015
|
0.75
|
96
|
The Somatotrope Growth Hormone-Releasing Hormone/Growth Hormone/Insulin-Like Growth Factor-1 Axis in Immunoregulation and Immunosenescence.
|
Front Horm Res
|
2017
|
0.75
|
97
|
The risk of pill cutter sharing.
|
Am J Med
|
2012
|
0.75
|
98
|
Computed Tomography Appearance of Surgically Resected Adrenal Hematomas.
|
J Comput Assist Tomogr
|
2016
|
0.75
|
99
|
Pituitary stem cells: review of the literature and current understanding.
|
Neurosurgery
|
2010
|
0.75
|
100
|
GH, but not GHRH, plays a role in the development of experimental autoimmune encephalomyelitis.
|
Endocrinology
|
2011
|
0.75
|
101
|
Quality of life in congenital, untreated, lifetime isolated growth hormone deficiency.
|
Psychoneuroendocrinology
|
2009
|
0.75
|
102
|
Autosomal-dominant isolated growth hormone deficiency (IGHD type II) with normal GH-1 gene.
|
Horm Res
|
2006
|
0.75
|
103
|
VENOUS SAMPLING FOR CUSHING DISEASE: COMPARISON OF INTERNAL JUGULAR VEIN AND INFERIOR PETROSAL SINUS SAMPLING.
|
Endocr Pract
|
2016
|
0.75
|
104
|
"Glandular intoxication" following emergent tracheotomy during transsphenoidal surgery for acromegaly: Cushing's 1910 unrecognized case of thyroid storm?
|
Pituitary
|
2012
|
0.75
|
105
|
Variations in referral patterns for hypophysectomies among pediatric patients with sellar and parasellar tumors.
|
Childs Nerv Syst
|
2009
|
0.75
|
106
|
Effect of dietary supplements of mussel and polychaetes on spawning performance of captive sole, Solea solea (Linnaeus, 1758).
|
Anim Reprod Sci
|
2008
|
0.75
|
107
|
Arrest of atherosclerosis progression after interruption of GH replacement in adults with congenital isolated GH deficiency.
|
Eur J Endocrinol
|
2012
|
0.75
|